English | Español
Patient Daily | Feb 3, 2026

How consumers can identify credible sources for evidence-based health decisions
Patient Daily | Feb 3, 2026

King's College London joins national effort to transform UK mental health research
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
Patient Daily | Feb 3, 2026

Rare pediatric disease voucher program reauthorized as part of narrowly approved spending bill
Patient Daily | Feb 3, 2026

Puerto Rico aims for revival as Amgen and Lilly invest billions in local facilities
Patient Daily | Feb 2, 2026

Study finds pink noise may reduce REM sleep quality
Patient Daily | Feb 2, 2026

Pharma faces mounting pressure over opaque drug pricing as calls grow for transparency
Patient Daily | Feb 2, 2026

FARE launches new PSA featuring Tia Mowry in Ready to Act campaign

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor